Xi Venture Capital was awarded the title of "Annual Healthcare Strategic Investment Institution"
Time：2024-05-10
On May 9th, the "2024 Future Medical Top 100" series list was officially announced. Xi Venture Capital was awarded the "Annual Medical and Health Strategic Investment Institution", and Fu Haiying, the Managing Director of the company's Biomedical team, was named the "Annual Medical and Health Youth Investor". Xi Venture Capital has invested in companies such as Zhenhe Technology, Hailai Xinchuang, Fanshengsheng, Likai Technology, Tangji Medical, Xiantong Pharmaceutical, Tainuo Mabo, Pegasus Biotech, and Dannuo Pharmaceutical, which made the list.
